港股创新药板块回落，博安生物(06955.HK)跌超6%%，再鼎医药(09688.HK)跌近4%，石药集团(01093.HK)跌超3%，百济神州(06160.HK)、翰森制药(03692.HK)等多股跟跌。

Group 1 - The Hong Kong innovative drug sector has experienced a decline, with notable drops in stock prices for several companies [1] - Biontech (06955.HK) fell over 6%, while Zai Lab (09688.HK) decreased nearly 4% [1] - Other companies such as CSPC Pharmaceutical (01093.HK), BeiGene (06160.HK), and Hansoh Pharmaceutical (03692.HK) also saw declines, with CSPC dropping over 3% [1]